Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Comment by perky38on Apr 06, 2014 10:22pm

207 Views

Post# 22418669

RE:RE:RE:reverse split

Thanks Pamplona

emx royalties are all over the world, I guess they are balanced in case some country nationalizes some mines. What is the short position on EMX?.

I own some GRO, insiders own allot of shares at much higher prices.

I think royalties like RGL, Franco Nevada, Calinan and Gold Royalties should out perform in this bull market in gold!. I think owning USD denominated royalties is the way to go. Fist the USD will go down(imo), then as the gold bull matures the USD will end up going UP!.(IMO)

GOOD LUCK

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading